Published in Vaccine on January 01, 1993
Respiratory syncytial virus infection in adults. Clin Microbiol Rev (2000) 3.16
Respiratory syncytial virus vaccines. Clin Microbiol Rev (1998) 1.38
Live-attenuated respiratory syncytial virus vaccines. Curr Top Microbiol Immunol (2013) 1.10
Respiratory syncytial virus vaccine development. Clin Lab Med (2009) 0.98
Isolation and characterization of bovine parainfluenza virus type 3 from water buffaloes (Bubalus bubalis) in Argentina. BMC Vet Res (2012) 0.80
Biochemical characterizations of two temperature-sensitive and attenuated strains of respiratory syncytial virus subgroup B. J Virol (1997) 0.78
Need for a safe vaccine against respiratory syncytial virus infection. Korean J Pediatr (2012) 0.75
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther (2009) 4.98
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Variations in surface protein composition associated with virulence properties in opacity types of Neisseria gonorrhoeae. J Gen Microbiol (1979) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Adherence of Neisseria gonorrhoeae to urethral mucosal cells: an electron-microscopic study of human gonorrhea. J Infect Dis (1972) 4.51
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
The human fallopian tube: a laboratory model for gonococcal infection. J Infect Dis (1974) 4.22
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Work of a district ethical committee. Br Med J (1979) 3.64
Gonococci in urethral exudates possess a virulence factor lost on subculture. Nature (1970) 3.19
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
The fate of gonococci in polymorphonuclear leucocytes. J Med Microbiol (1970) 2.75
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
The preservation of gonococci in liquid nitrogen. J Clin Pathol (1971) 2.30
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Biological properties of two distinct pilus types produced by isogenic variants of Neisseria gonorrhoeae P9. J Bacteriol (1980) 2.20
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
Studies on lipopolysaccharides isolated from strains of Neisseria gonorrhoeae. J Gen Microbiol (1975) 2.08
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Coronaviridae: second report. Intervirology (1978) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors. Proc Natl Acad Sci U S A (1996) 1.93
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
Gamma-M deficiency predisposing to meningococcal septicaemia. Br Med J (1967) 1.88
An evaluated programme of rheumatology training for general practitioners. Br J Rheumatol (1986) 1.88
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain (1996) 1.83
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
Genotyping of Chlamydia trachomatis from a trachoma-endemic village in the Gambia by a nested polymerase chain reaction: identification of strain variants. J Infect Dis (1992) 1.81
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Changes in incidence and aetiology of bacteraemia arising in hospital practice. Br Med J (1967) 1.76
Studies on the Inoculation and Competitiveness of a Rhizobium leguminosarum Strain in Soils Containing Indigenous Rhizobia. Appl Environ Microbiol (1985) 1.74
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Maintenance of virulent gonococci in laboratory culture. Nat New Biol (1972) 1.65
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
The fate of gonococci in polymorphonuclear leucocytes: an electron microscopic study of the natural disease. Br J Exp Pathol (1972) 1.62
A comparison of serological tests for the diagnosis of gonorrhoea. Br J Vener Dis (1971) 1.61
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632. Antimicrob Agents Chemother (2000) 1.59
Further trials of live influenza vaccine. Br Med J (1966) 1.58
The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58
Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol (1983) 1.58
Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57
Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55
Coronaviridae. Intervirology (1975) 1.55
Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54
Radial dose distribution of 192Ir and 137Cs seed sources. Med Phys (1989) 1.48
A mathematical model of common-cold epidemics on Tristan da Cunha. J Hyg (Lond) (1971) 1.47
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health (1993) 1.43
Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42
The radiation dosimetry of 99Tcm-exametazime. Nucl Med Commun (1990) 1.39
Live influenza vaccines. Lancet (1983) 1.39
Role of general practitioners in care of long-term mentally ill patients. Br J Psychiatry (1991) 1.39
Extent and kinetics of genetic change in the omp1 gene of Chlamydia trachomatis in two villages with endemic trachoma. J Infect Dis (1995) 1.38
Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38
Fibromyalgia and women's pursuit of personal goals: a daily process analysis. Health Psychol (1998) 1.38
Picornaviridae. Intervirology (1974) 1.36
Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1983) 1.35
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33
Should negative affectivity remain an unmeasured variable in the study of job stress? J Appl Psychol (1988) 1.31
Antibody responses to and efficacy of an inactivated spray vaccine. Bull World Health Organ (1969) 1.29
Bacteriological colonisation of uterine cavity: role of tailed intrauterine contraceptive device. Br Med J (Clin Res Ed) (1981) 1.28
Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1998) 1.28
Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet (1981) 1.27
Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother (1987) 1.27
Titration of tuberculin, nucleic acids and viruses by haemaggregation inhibition using a "pattern" test. Br J Exp Pathol (1967) 1.26
An epidemic of influenza on Tristan da Cunha. J Hyg (Lond) (1973) 1.26
Identification of rhinovirus stran D.C. Nature (1968) 1.24
Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23
Skin tests with influenza virus. J Hyg (Lond) (1973) 1.22
Viruses in febrile convulsions. Lancet (1980) 1.22
Possible virus in schizophrenia and some neurological disorders. Lancet (1979) 1.21
Purified interferon as protection against rhinovirus infection. Br Med J (Clin Res Ed) (1982) 1.21
Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol (2001) 1.19